Stents are metal scaffolds used for opening the blocked vessel to optimize the flow of biliary fluid or blood through the vessel. Biodegradable stents also called as bioresorbable stents are type of stents made from special biodegradable material such as polymers and metal, eliminating the stents removal and side-effects of conventional stents. Biodegradable polymers evaluated for stent manufacture are polylactic acid (PLA), poly-DL-lactic acid (PDLLA), poly-L-lactic acid (PLLA), poly-DL-lactide-co-glycolide (PDLGA), poly-lactic-co glycolide (PLGA), polycaprolactone (PCL), polylactic acid/polycaprolactone (PLA/PCL), whereas biodegradable metal are made up of magnesium, stainless steel, and cobalt chromium. Biodegradable material hydrolyze in presence of water and convert into simple biological compounds.

The global biodegradable stents market size is estimated to be valued at US$ 278.6 million in 2018, and is expected to witness a CAGR of 15.6% over the forecast period (2018 – 2026).

High risk of developing cardiovascular disease is expected to fuel the biodegradable stents market growth over the forecast period. For instance, according to American Heart Association, cardiovascular disease is a leading cause of death worldwide, owning for more than 17.3 million deaths per year in 2013, comprising around 31% and number is expected to grow to more than 23.6 million by 2030.

Moreover, as per American Heart Association’s Heart Disease and Stroke Statistics 2017, 39.7% of American adults suffer from high cholesterol, which is projecting them towards higher

risk of arterial blockage. Furthermore, sedentary lifestyle and increasing proportion of obesity and geriatric population is also expected to drive growth of the biodegradable stents market.

Biodegradable stents are gaining traction and adoption attributing to drawbacks of bare metal stents. For instance, bare metal stents are reported to cause hypersensitivity reaction and issues such as late drug eluting stents thrombosis. However, high cost of the biodegradable stents is the major factor hindering the market growth.

The regional biodegradable stents market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. Europe holds dominant position in biodegradable stents market, owing to presence of large number of approved products in the region. On the other hand, the market in North America is expected to experience growth gradually once there approved products sail through successfully in the market. Moreover, there is increasing prevalence of cardiac blockage due to sedentary lifestyle in the region. For instance, according to Center for Disease Control and Prevention (CDC), the three major factor leading to heart disease are high blood pressure, high cholesterol, and smoking, which has prevalence of 47% of the American population attributing to the disease prone population. However, biodegradable stents market in Asia Pacific is expected to witness significant growth, owing increasing medical tourism and increasing adoption of biodegradable stents. Moreover, emerging economies such as India and China offers wide opportunity for the market players, which is fuelling growth of the regional biodegradable stents market.

The global biodegradable stents market growth is also driven by the inorganic strategies of the market players. For instance, in 2015, Cardinal Health acquired Cordis, a subsidiary of Johnson & Johnson, for US$ 1.9 billion. The acquisition will roll on the Cordis’s S.M.A.R.T., vascular stents system.

Biodegradable stents are medical devices made up of bio-absorbable material such as polymer or metal used to achieve normal flow of blood or other bloodily fluids in case of clogged or narrowed vessels. The report delivers concise and clear in-depth analysis of market size and market growth under the scope product type, material type, and end users. Furthermore, report tracks the recent product launches, and trends driving the biodegradable stents market. However, report also focuses on the factors which are hindering the global biodegradable stents market growth.

Market Dynamics

Factors such as increasing product launches with biodegradable material or technologically advanced form such as completely degradable stents and increasing incidences of cardiac coronary artery disease are driving the biodegradable stents market growth. For instance, in 2016, Biotronik SE & Co. received CE approval for Magmaris, which is first clinically-proven magnesium scaffold based bioresorbable stents for the treatment of coronary artery disease. Moreover, the pipeline product are aiding to the biodegradable stents market growth over the forecast period. For instance, Scitech Produtos Medicos Ltda is conducting clinical trials for Inspiron stents and biomatrix flex stents for the coronary artery disease, which as on April 2018, was in phase 4 trial. However, the drawbacks associated with polymer such as expansion and recoiling of stents, are expected to restrain the biodegradable stents market growth.

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

It profiles leading players in the global biodegradable stents market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, distribution channel upgrades, market expansion and marketing tactics.

The global biodegradable stents market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers of biodegradable stents, research and consulting firms, new entrants, and financial analysts

Various strategy matrices used in analyzing the biodegradable stents market would provide stakeholders vital inputs to make strategic decisions accordingly

Detailed Segmentation:

Global Biodegradable Stents Market, By Product Type:

Coronary Stents

Peripheral Stents

Global Biodegradable Stents Market, By Material Type:

Polymer-based Stents

Metallic Stents

Global Biodegradable Stents Market, By End Users:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

Global Biodegradable Stents Market, By Region:

North America

By Product Type:

Coronary Stents

Peripheral Stents

By Material Type:

Polymer-based Stents

Metallic Stents

By End Users:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Country:

U.S.

Canada

Latin America

By Product Type:

Coronary Stents

Peripheral Stents

By Material Type:

Polymer-based Stents

Metallic Stents

By End Users:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

Europe

By Product Type:

Coronary Stents

Peripheral Stents

By Material Type:

Polymer-based Stents

Metallic Stents

By End Users:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Country:

Germany

U.K.

Italy

France

Spain

Russia

Rest of Europe

Asia Pacific

By Product Type:

Coronary Stents

Peripheral Stents

By Material Type:

Polymer-based Stents

Metallic Stents

By End Users:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Country:

China

India

Japan

ASEAN

Australia

South Korea

Rest of Asia Pacific

Middle East

By Product Type:

Coronary Stents

Peripheral Stents

By Material Type:

Polymer-based Stents

Metallic Stents

By End Users:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Country:

GCC

Israel

Rest of Middle East

Africa

By Product Type:

Coronary Stents

Peripheral Stents

By Material Type:

Polymer-based Stents

Metallic Stents

By End Users:

Hospitals

Specialty Clinics

Ambulatory Surgical Centers

By Country:

North Africa

Central Africa

South Africa

Company Profiles

Boston Scientific Corporation*

Company Overview

Product Portfolio

Key Highlights

Financial Overview

Market Strategies

Abbott

Kyoto Medical Planning Co., Ltd.

QualiMed

Elixir Medical Corporation

ENDOCOR GmbH

BIOTRONIK SE & Co. KG

Amaranth Medical, Inc.

Arterial Remodeling Technologies SA

“*” marked represents similar segmentation in other categories in the respective section.

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

Primary Research (Trade Surveys and Experts Interviews)

Desk Research

Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Coherent Market Insights desk research is based on a principle set of research techniques:

National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.

Trade association, National and international media and trade press.

Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.

Scientific journals, and other technical magazines and whitepapers.

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

Micro-economic indicators

Macro-economic indicators

Environmental indicators

Socio-political indicators

Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

It provides first-hand information on the market dynamics, outlook, and growth parameters.

Industry experts validates the estimates which helps the company to cement the on-going research study.